Investigating the effects of two novel 4-MMPB analogs as potent lipoxygenase inhibitors for prostate cancer treatment

BACKGROUND: Lipoxygenases are one of the critical signaling mediators which can be targeted for human prostate cancer (PC) therapy. In this study, 4-methyl-2-(4-methylpiperazinyl)pyrimido[4,5-b]benzothiazine (4-MMPB) and its two analogs, 4-propyl-2-(4-methylpiperazinyl)pyrimido[4,5-b]benzothiazine (...

Descripción completa

Detalles Bibliográficos
Autores principales: Iranpour, Sonia, Al-Mosawi, Aseel Kamil Mohammed, Bahrami, Ahmad Reza, Sadeghian, Hamid, Matin, Maryam M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097893/
https://www.ncbi.nlm.nih.gov/pubmed/33947474
http://dx.doi.org/10.1186/s40709-021-00141-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097893/
https://www.ncbi.nlm.nih.gov/pubmed/33947474
http://dx.doi.org/10.1186/s40709-021-00141-w

Ejemplares similares